` CBUS (Cibus Inc) vs S&P 500 Comparison - Alpha Spread

CBUS
vs
S&P 500

Over the past 12 months, CBUS has underperformed S&P 500, delivering a return of -85% compared to the S&P 500's 9% growth.

Stocks Performance
CBUS vs S&P 500

Loading
CBUS
S&P 500
Add Stock

Performance Gap
CBUS vs S&P 500

Loading
CBUS
S&P 500
Difference
www.alphaspread.com

Performance By Year
CBUS vs S&P 500

Loading
CBUS
S&P 500
Add Stock

Competitors Performance
Cibus Inc vs Peers

S&P 500
CBUS
ABBV
AMGN
GILD
VRTX
Add Stock

Cibus Inc
Glance View

Market Cap
48m USD
Industry
Biotechnology

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 228 full-time employees. The company went IPO on 2017-07-20. The firm is engaged in developing and licensing plant traits to seed companies for royalties on seed sales. The firm is involved in gene-edited trait development, where plant traits (or specific genetic characteristics) that are indistinguishable from traits developed using traditional breeding are created using gene editing. Its patented RTDS technology platform includes the Trait Machine, which is a semi-automated stand-alone trait production facility. The Company’s Trait Machine materially changes the speed, breadth, and scale of trait development. The company is focused on the development of productivity traits and sustainable ingredients. The firm focuses on developing traits for addressing the sustainability challenges presented by climate change, disease, and pests.

CBUS Intrinsic Value
Not Available
C
Back to Top